The use of ecstasy is a public health problem and is associated with a range of social costs and harms. Recently, there has been growing concern about the misuse of new psychoactive substances (NPS) designed to mimic the effects of illicit drugs, including ecstasy.
Prevention and early intervention
Anxiety, depressive and substance use disorders account for three quarters of the disability attributed to mental disorders. Moreover, research indicates that these disorders are often comorbid, share common risk factors and interact.
Alcohol exposure in utero can cause a range of abnormalities in the fetus which are included under the umbrella term Fetal Alcohol Spectrum Disorders (FASD).
The Triple B Study: Bumps, Babies and Beyond is an innovative Australian study of approximately 1600 families. The project is a longitudinal pregnancy cohort which examines a wide range of biopsychosocial factors that relate to the health and development of Australian children and families.
Governments, policy experts, researchers and randomly selected members of communities all support the idea of greater co-ordination of efforts aimed at reducing alcohol-related harm.
The Triple B study (Bumps, Babies and Beyond) is a large NHMRC-funded birth cohort study which examines the effects of substance use in pregnant women and their partners during the prenatal period on infant development and family functioning.
Mental health and substance use disorders account for more years of life lost due to disability than any other disorders. These disorders often occur together (comorbidity), affecting more than 300,000 Australians every year.
The increased use of psychostimulants in Australia is a major concern. People using psychostimulants often do not access traditional treatment services, as their need is often greatest outside of regular office hours.
Alcohol use during pregnancy has been associated with a number of adverse pregnancy outcomes including miscarriage, premature birth, still birth and low birth weight.
To review, update and add new information reflecting current drug trends to inform content included on the National Drugs Campaign (NDC) website.